The analysis of the obtained results, taking into account the grade of diagnosed gastric cancer, showed a statistically significant increase in the percentage of almost all tested populations of immune system cells expressing TLR2, with the exception of classical monocytes CD14+CD16-, with the increase in cancer advancement (Table 4). The gene discussed is TLR2; the disease is cancer.